SCHEMBL5357964

SCHEMBL5357964

ICc1nnnn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.35
NPSR1 Q6W5P4 2/20 0.35
HTT P42858 3/20 0.34
PKM P14618 2/20 0.34
NLRP3 Q96P20 1/20 0.34
ALDH1A1 P00352 4/20 0.33
POLB P06746 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
AGTR1 P30556 1/20 0.32
AGTR2 P50052 1/20 0.32
HSD11B1 P28845 2/20 0.32
KDM4C Q9H3R0 1/20 0.31
THRB P10828 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KMT2A Q03164 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
CCR6 P51684 1/20 0.31
CACNA1B Q00975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8418644 0.84 DAGLA (0.35) LMNANPSR1HTTPKMNLRP3
SCHEMBL8417361 0.83 DAGLA (0.34) LMNANPSR1HTTPKMNLRP3
SCHEMBL1121488 0.83 LMNA (0.35) LMNANPSR1HTTPKMNLRP3
SCHEMBL6854704 0.83 ALDH1A1 (0.39) LMNANPSR1HTTPKMNLRP3
SCHEMBL2359649 0.83 LMNA (0.35) LMNANPSR1HTTPKMNLRP3
SCHEMBL9087766 0.81 CNR2 (0.41) ALDH1A1POLBHSD11B1KMT2A
SCHEMBL14032263 0.80 AGTR1 (0.35) LMNANPSR1HTTPKMNLRP3
SCHEMBL22615880 0.80 HSD11B1 (0.36) LMNANPSR1ALDH1A1AGTR1AGTR2
SCHEMBL3260686 0.80 CYP2A6 (0.34) LMNANPSR1HTTPKMNLRP3
SCHEMBL2164161 0.79 KDM4C (0.40) LMNAALDH1A1POLBHSD11B1KDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007145349-A2 SUBSTITUTED PYRROLE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-12-21 WO disclosed
CN-1227261-C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action MENARINI RICERCHE SPA (IT) 2005-11-16 CN disclosed
US-6780968-B1 NEUROKININ-2 (NK-2) ANTAGONISTS USEFUL IN THE TREATMENT OR PREVENTION OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM, INFLAMMATORY DISEASES, ASTHMA, OR PAIN MENARINI RICERCHE S.P.A. (IT) 2004-08-24 US disclosed
EP-1017711-B1 MONOCYCLIC COMPOUNDS WITH FOUR BIFUNCTIONAL RESIDUES HAVING NK-2 ANTAGONIST ACTION MENARINI RICERCHE SPA (IT) 2003-07-23 EP disclosed
EP-1017711-A2 MONOCYCLIC COMPOUNDS WITH FOUR BIFUNCTIONAL RESIDUES HAVING NK-2 ANTAGONIST ACTION Menarini Ricerche S.p.A. (IT) 2000-07-12 EP disclosed
CN-1246866-A Monocyclic compound with four bifunctional groups and NK-2 antagonistic effect MENARINI RICERCHE SPA (IT) 2000-03-08 CN disclosed
EP-0684257-B1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them ADIR (FR) 1999-09-22 EP disclosed
WO-1998034949-A2 MONOCYCLIC COMPOUNDS WITH FOUR BIFUNCTIONAL RESIDUES HAVING NK-2 ANTAGONIST ACTION MENARINI RICERCHE S.P.A. (IT) 1998-08-13 WO disclosed
US-5561113-A ANALGESICS; ANTIIFLAMMATORY AGENTS; GASTROINTESTINAL, UROGENITAL AND NERVOUS SYSTEM(CNS) DISORDERS; ASTHMA; ANTIALLERGENS ADIR ET COMPAGNIE (FR) 1996-10-01 US disclosed
CN-1120548-A New pseudopeptide compounds of neurokinins, process for preparing them and pharmaceutical compositions containing them ADIR (FR) 1996-04-17 CN disclosed
EP-0684257-A1 Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them ADIR ET COMPAGNIE (FR) 1995-11-29 EP disclosed